Executive Leadership and Management Teams at Florida Cancer Specialists & Research Institute
Leaders in Cancer Care – We are proud of our tremendous track record and the momentum we are creating at the forefront of science and research. FCS remains successful in building the fundamental infrastructure that includes innovative technologies, the finest clinical experts and critical partnerships that will carry us far into the future. We are committed to providing world-class cancer care in community-based settings close to home.
Executive Leadership Team
View profile
Ken Sturtz
Chief Information & Administrative Officer
View profile
Paul Chadwick
Chief Value and Procurement Officer
View profile
Josh Eaves
Chief Development & Strategy Officer
Senior Management
View profile
Skip Boykin
Vice President, Enterprise Applications
View profile
Dawn Hackney
Vice President Financial Planning & Analysis
View profile
Trevor Heritage, Ph.D.
Senior Vice President & Data Officer
View profile
Tara Lambert, CPA
Vice President & Controller, Accounting
View profile
Sharon Lapkin, MS, RN, CPHRM
Vice President, Enterprise Risk Management
View profile
Colleen Lewis, MSN, ANP-BC, AOCNP
Vice President, Nursing and Research
View profile
Jon Meyers
Vice President, Physician Compensation
View profile
Chris Purdy, CPA, MBA
Vice President, Internal Audit & Process Controls
View profile
Nicole Radford, FACHE, MS, MT(ASCP)
Vice President, Laboratory Services
View profile
Frank Scimeca, PharmD, MBA, BCOP
Vice President, Pharmacy Services
View profile
Samantha Watkins
Vice President, Operations and Special Projects
View profile
Tonja A. Wise, CHC, CHPC, CCS
Vice President, Chief Compliance Officer
May 1, 2024
New Case Study Highlights Community Oncology Practices as Preferred Site of Service Over Hospitals and Academic Centers
April 29, 2024
Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology Fellows
April 25, 2024
New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
April 25, 2024
Lucio N. Gordan, MD Discusses Findings of Phase 3 Clinical Trial Supporting Advanced Treatments for Multiple Myeloma in National Broadcast